Evidence map›Paper›PMID 23853095›Full record

ArticleThe Journal of biological chemistry2013

Per-Arnt-Sim kinase regulates pancreatic duodenal homeobox-1 protein stability via phosphorylation of glycogen synthase kinase 3β in pancreatic β-cells.

Meriem Semache, Bader Zarrouki, Ghislaine Fontés, Sarah Fogarty, Chintan Kikani, Mohammad B Chawki, Jared Rutter, Vincent Poitout

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Protein Kinases Signaling in Pancreatic Beta-cells Death and Type 2 Diabetes.Advances in experimental medicine and biology · 2021
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Meriem SemacheMontreal Diabetes Research Center, CRCHUM, Quebec City H1W4A4, Canada.
Bader Zarrouki
Ghislaine Fontés
Sarah Fogarty
Chintan Kikani
Mohammad B Chawki
Jared Rutter
Vincent Poitout
Diabetes Research CenterUniversity of Utah · USUniversité de Montréal · CA

Funding

Neutral lipid dysregulation of the pancreatic beta-cellR01DK058096 · NIDDK · UNIVERSITY OF MONTREAL HOSPITAL · PI POITOUT, VINCENT · 2001 to 2020
$3.9M
The role of PAS kinase in hepatic lipid metabolismR01DK071962 · NIDDK · UNIVERSITY OF UTAH · PI RUTTER, JARED P · 2005 to 2013
$2.4M
NIDDK NIH HHS R01 DK058096NIDDK NIH HHS R01 DK-071962NIDDK NIH HHS R01 DK071962NIDDK NIH HHS R01 DK-58096
6 · The paper itself

Abstract

In pancreatic β-cells, glucose induces the binding of the transcription factor pancreatic duodenal homeobox-1 (PDX-1) to the insulin gene promoter to activate insulin gene transcription. At low glucose levels, glycogen synthase kinase 3β (GSK3β) is known to phosphorylate PDX-1 on C-terminal serine residues, which triggers PDX-1 proteasomal degradation. We previously showed that the serine/threonine Per-Arnt-Sim domain-containing kinase (PASK) regulates insulin gene transcription via PDX-1. However, the mechanisms underlying this regulation are unknown. In this study, we aimed to identify the role of PASK in the regulation of PDX-1 phosphorylation, protein expression, and stability in insulin-secreting cells and isolated rodent islets of Langerhans. We observed that glucose induces a decrease in overall PDX-1 serine phosphorylation and that overexpression of WT PASK mimics this effect. In vitro, PASK directly phosphorylates GSK3β on its inactivating phosphorylation site Ser(9). Overexpression of a kinase-dead (KD), dominant negative version of PASK blocks glucose-induced Ser(9) phosphorylation of GSK3β. Accordingly, GSK3β Ser(9) phosphorylation is reduced in islets from pask-null mice. Overexpression of WT PASK or KD GSK3β protects PDX-1 from degradation and results in increased PDX-1 protein abundance. Conversely, overexpression of KD PASK blocks glucose-induction of PDX-1 protein. We conclude that PASK phosphorylates and inactivates GSK3β, thereby preventing PDX-1 serine phosphorylation and alleviating GSK3β-mediated PDX-1 protein degradation in pancreatic β-cells.

Indexed as

AnimalsGlucoseGlycogen Synthase Kinase 3Glycogen Synthase Kinase 3 betaHep G2 CellsHomeodomain ProteinsHumansInsulin-Secreting CellsMaleMiceMutationPhosphorylationProtein Serine-Threonine KinasesProtein StabilityRatsRats, WistarGlucoseGlycogen Synthase Kinase 3Glycogen Synthase Kinase 3 betaGSK3B protein, humanGsk3b protein, mouseGsk3b protein, ratHomeodomain Proteinspancreatic and duodenal homeobox 1 proteinPAS domain kinasesProtein Serine-Threonine KinasesSweetening AgentsTrans-ActivatorsDiabetesGlycogen Synthase Kinase 3InsulinPancreatic Duodenal Homeobox-1Pancreatic Isletsβ-Cell

Identifiers

PMID23853095
PMCPMC3750177
OpenAlexW2052632576

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.